ANXA1 and melanoma: ANXA1 expression has been reported to correlate with the development of hepatocellular carcinoma (HCC) [44], colorectal cancer (CRC) [45,46], lung cancer [47], pancreatic cancer [48], melanoma [49] and skin cancer [50].